MDLinx Psychiatry is your one-stop shop for the peer-reviewed journal articles published in your field. We sort, rank and summarize the literature within 24 hours – hot off the presses! – so you can stay current without drowning in those piles of Current Psychiatry, Bipolar Disorders, and American Journal of Psychiatry. Also find bonus content like clinical pearls from The Smartest Psychiatrist Physician Review and daily quiz competition. Not sure where to start? Skim some of the recent “must read” articles highlighted by our own physician editor D. Scott Cunningham, MD, PhD.
Your Unread Messages in Psychiatry
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Patients 50+ may be at increased risk for pneumococcal disease. Learn what you can do.
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Depression increases risk of stroke in women
Jill Baker
MDLinx Career Center
New Jobs in Your Specialty
MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?
MDLinx Conference Center
MDLinx
June Conference Calendar
1 A pilot open-label trial of minocycline in patients with autism and regressive features Full Text Journal of Neurodevelopmental Disorders, June 18, 2013 Clinical Article
2 Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases Neuropsychopharmacology, June 18, 2013 Clinical Article
3 Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia Full Text Neuropsychiatric Disease and Treatment, June 17, 2013
4 The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression International Clinical Psychopharmacology, June 14, 2013 Clinical Article
5 Effects of escitalopram on attentional bias to cocaine-related stimuli and inhibitory control in cocaine-dependent subjects Journal of Psychopharmacology, June 14, 2013 Clinical Article
6 Antidepressant medication in patients with advanced cancer - an observational study QJM: An International Journal of Medicine, June 14, 2013 Evidence Based Medicine
7 Antidepressant use during early pregnancy and the risk of congenital anomalies Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, June 14, 2013 Clinical Article
8 Quetiapine versus typical antipsychotic medications for schizophrenia Cochrane Reviews, June 13, 2013 Clinical Article
9 Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar i disorder: analysis of two large randomized, placebo-controlled trials Depression and Anxiety, June 13, 2013 Clinical Article
10 Pharmacological interventions for smoking cessation: an overview and network meta-analysis Cochrane Reviews, June 12, 2013 Evidence Based Medicine Review Article
11 Modulation of attention network activation under antidepressant agents in healthy subjects International Journal of Neuropsychopharmacology, June 12, 2013 Clinical Article
12 D-amino acid aberrations in cerebrospinal fluid and plasma of smokers Neuropsychopharmacology, June 12, 2013 Clinical Article
13 Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: results from a multisite study Drug and Alcohol Dependence, June 11, 2013 Clinical Article
14 Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg American Journal of Psychiatry, June 11, 2013 Clinical Article
15 Cost-effectiveness of adherence therapy versus health education for people with schizophrenia: randomised controlled trial in four European countries Full Text Cost Effectiveness and Resource Allocation, June 11, 2013 Clinical Article
16 The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study Drug and Alcohol Dependence, June 10, 2013 Clinical Article
17 The effectiveness comparison of Jitai tablets versus methadone in community-based drug treatment: A 1 year follow-up study Addictive Behaviours, June 7, 2013 Clinical Article
18 The impact of a single administration of intranasal oxytocin on the recognition of basic emotions in humans: a meta-analysis Neuropsychopharmacology, June 7, 2013 Evidence Based Medicine Review Article
19 Multi-modality: a new approach for the treatment of major depressive disorder International Journal of Neuropsychopharmacology, June 6, 2013 Review Article
20 Tianeptine combination for partial or non-response to selective serotonin re-uptake inhibitor monotherapy Psychiatry and Clinical Neurosciences, June 6, 2013 Clinical Article
As published in the American Journal of Obstetrics and Gynecology, risk factors for postpartum depression among abused women included age 15-19 (aOR=2.29) and > 35 years of age (aOR=2.33). In non-abused women, risk factors for postpartum depression include unemployment (aOR=1.41), foreign birth (aOR=2.04), and low income (aOR=1.68). Postpartum depression was also associated with women abused prior to pregnancy (aOR=3.28), abuse beginning postpartum (aOR=4.76), and abuse resuming postpartum (aOR=3.81).
Read the article summaryAs published in the British Journal of Psychiatry, low cardiovascular fitness at 18 years of age (n = 1,117,292; follow-up, 3-40 y) is associated with an increased risk of severe depression (HR = 1.96).
Read the article summaryAs published in Clinical Drug Investigation, an initial amisulpride dose of 800 mg (n=38) is more effective that 400 mg with dose titration (n=30) in patients with an acute exacerbation of schizophrenia. A greater number of patients in the 800 mg group than the 400 mg with dose titration group had a 30% reduction in the Positive and Negative Symptom Scale after 4 (68.4% vs. 40.0%) and 6 weeks (71.1% vs. 43.3%).
Read the article summary1 Post-traumatic stress disorder: new directions in pharmacotherapy Advances in Psychiatric Treatment, May 3, 2013 Review Article
2 The Combined Treatment of Venlafaxine and Quetiapine for Treatment-Resistant Depression: A Clinical Study The Journal of Neuropsychiatry & Clinical Neurosciences, May 21, 2013
3 Curcumin as an Add-On to Antidepressive Treatment: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Study Clinical Neuropharmacology, May 16, 2013
4 Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers Human Psychopharmacology: Clinical and Experimental, May 13, 2013
5 Efficacy and safety of fluoxetine monotherapy in bipolar depression: a systematic review Expert Opinion on Pharmacotherapy, May 22, 2013
6 Lithiums role in neural plasticity and its implications for mood disorders Acta Psychiatrica Scandinavica, May 1, 2013 Review Article
7 Benzodiazepines for psychosis-induced aggression or agitation Cochrane Reviews, May 9, 2013
8 Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimers disease Alzheimer's & Dementia, May 14, 2013 Review Article
9 Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study Neuropsychiatric Disease and Treatment, April 18, 2013 Free full text
10 Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: A double blind, placebo-controlled study Psychiatry Research, May 2, 2013
11 Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: A 12-week randomized, flexible-dose, open-label trial Schizophrenia Research, May 6, 2013
12 The sertraline versus electrical current therapy for treating depression clinical study (SELECT-TDCS): results of the crossover and follow-up phases Depression and Anxiety, April 29, 2013
13 Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial Journal of Affective Disorders, May 17, 2013
14 Treatment or "high": benzodiazepine use in patients on injectable heroin or oral opioids Addictive Behaviours, May 24, 2013
15 Mood disorders and complementary and alternative medicine: a literature review Neuropsychiatric Disease and Treatment, May 29, 2013 Free full text Review Article
16 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013 Evidence Based Medicine
17 Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 13, 2013 Evidence Based Medicine
18 Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy Addiction, May 15, 2013
19 Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders Neuropsychiatric Disease and Treatment, May 7, 2013 Free full text
20 Amphetamine, past and present - a pharmacological and clinical perspective Journal of Psychopharmacology, May 16, 2013 Review Article
Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addiction more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close